A novel pathogenic mitochondrial DNA variant m.4344T>C in tRNA Gln causes developmental delay

Xiaojie Yin,Qiyu Dong,Shuanglong Fan,Lina Yang,Hao Li,Yijun Jin,Mahlatsi Refiloe Laurentinah,Xiandan Chen,Aliaksei Sysa,Hezhi Fang,Jianxin Lyu,Yongguo Yu,Ya Wang
DOI: https://doi.org/10.1038/s10038-024-01254-5
2024-05-10
Journal of Human Genetics
Abstract:Mitochondrial diseases are a group of genetic diseases caused by mutations in mitochondrial DNA and nuclear DNA. However, the genetic spectrum of this disease is not yet complete. In this study, we identified a novel variant m.4344T>C in mitochondrial tRNA Gln from a patient with developmental delay. The mutant loads of m.4344T>C were 95% and 89% in the patient's blood and oral epithelial cells, respectively. Multialignment analysis showed high evolutionary conservation of this nucleotide. TrRosettaRNA predicted that m.4344T>C variant would introduce an additional hydrogen bond and alter the conformation of the T-loop. The transmitochondrial cybrid-based study demonstrated that m.4344T>C variant impaired the steady-state level of mitochondrial tRNA Gln and decreased the contents of mitochondrial OXPHOS complexes I, III, and IV, resulting in defective mitochondrial respiration, elevated mitochondrial ROS production, reduced mitochondrial membrane potential and decreased mitochondrial ATP levels. Altogether, this is the first report in patient carrying the m.4344T>C variant. Our data uncover the pathogenesis of the m.4344T>C variant and expand the genetic mutation spectrum of mitochondrial diseases, thus contributing to the clinical diagnosis of mitochondrial tRNA Gln gene variants-associated mitochondrial diseases.
genetics & heredity
What problem does this paper attempt to address?